Largest Swiss (SMI) Pharmaceuticals & Biotech Stocks by Market Cap

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Sep 24, 2025

Discover large cap Swiss Pharmaceuticals & Biotech companies that are on the SMI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
ROG Roche Holding	CHF 259.90	-0.2%	-4.3%	CHF 223.1b	CHF 297.50	PE23.4x	E13.7%	3.7%
NOVN Novartis	CHF 97.83	1.3%	-1.5%	CHF 189.4b	CHF 98.63	PE17.4x	E8.2%	3.1%
LONN Lonza Group	CHF 524.60	-3.9%	-1.6%	CHF 36.8b	CHF 676.18	PE50.3x	E20.7%	0.8%
GALD Galderma Group	CHF 140.00	-3.6%	75.6%	CHF 33.2b	CHF 141.13	PE110.5x	E32.0%	0.04%
SDZ Sandoz Group	CHF 47.16	-1.5%	33.5%	CHF 20.3b	CHF 49.22	PE112.5x	E27.9%	1.1%
BANB Bachem Holding	CHF 62.55	-2.3%	-10.3%	CHF 4.7b	CHF 77.88	PE34.9x	E17.9%	1.4%
DESN Dottikon ES Holding	CHF 301.00	1.5%	18.5%	CHF 4.2b	CHF 357.63	PE39.4x	S12.7%	0%
SFZN Siegfried Holding	CHF 80.30	-7.2%	-29.8%	CHF 3.5b	CHF 110.07	PE22.8x	E11.0%	0.5%
TECN Tecan Group	CHF 154.60	-1.8%	-41.9%	CHF 2.0b	CHF 220.64	PE31.1x	E16.4%	1.9%
SKAN SKAN Group	CHF 54.80	-5.8%	-30.7%	CHF 1.2b	CHF 82.67	PE76.2x	E28.2%	0.7%
COPN Cosmo Pharmaceuticals	CHF 65.00	-2.7%	-15.5%	CHF 1.0b	CHF 87.81	PE18.5x	E35.2%	2.9%
KURN Kuros Biosciences	CHF 24.02	1.7%	31.4%	CHF 927.5m	CHF 31.00	PS9x	E54.2%	n/a
PPGN PolyPeptide Group	CHF 24.30	-6.2%	-20.1%	CHF 801.7m	CHF 34.93	PS2.3x	E66.9%	0%
IDIA Idorsia	CHF 3.72	-9.2%	141.4%	CHF 777.6m	CHF 4.00	PS3.6x	E29.7%	n/a
BSLN Basilea Pharmaceutica	CHF 46.25	0.4%	-1.9%	CHF 568.3m	CHF 90.42	PE7.8x	E7.1%	0%
NWRN Newron Pharmaceuticals	CHF 10.90	13.1%	45.3%	CHF 217.6m	CHF 18.04	PE9.2x	E45.2%	n/a
BIOV BioVersys	CHF 29.00	-6.8%	n/a	CHF 169.5m	CHF 60.00	PS129.5x	E-4.2%	n/a
SANN Santhera Pharmaceuticals Holding	CHF 10.92	-24.0%	21.2%	CHF 141.6m	CHF 30.00	PS2.9x	S53.4%	n/a
XLS Xlife Sciences	CHF 20.90	4.0%	-30.3%	CHF 120.5m	n/a	PE3.5x	n/a	n/a
MOLN Molecular Partners	CHF 2.85	0.9%	-28.9%	CHF 106.6m	CHF 9.25	PS156.5x	E-4.5%	n/a
CURN Curatis Holding	CHF 13.25	9.5%	76.7%	CHF 66.1m	CHF 84.50	n/a	n/a	n/a
RLF Relief Therapeutics Holding	CHF 3.00	1.0%	15.4%	CHF 37.8m	n/a	PS9.3x	n/a	n/a
ADXN Addex Therapeutics	CHF 0.068	0%	-8.9%	CHF 6.7m	n/a	PS27.1x	S62.6%	n/a